Matches in SemOpenAlex for { <https://semopenalex.org/work/W2545068059> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2545068059 endingPage "e12009" @default.
- W2545068059 startingPage "e12009" @default.
- W2545068059 abstract "e12009 Background: This study describes patterns of care and outcomes in metastatic breast cancer (MBC) patients treated with trastuzumab (T) within the US Oncology network. Methods: This retrospective study utilized data from US Oncology's iKnowMed EMR system. HER-2 (+) MBC patients who initiated a first-line regimen containing T between January 1, 2006 and July 31, 2007, were identified. Patients were divided into three treatment cohorts: A) those who discontinued T prior to disease progression; B) those who continued T following discontinuation of chemotherapy prior to progression; and C) those who received T monotherapy. Patients were followed through October 31, 2008, to measure treatment duration and observe progression (as defined as escalation to second-line therapy). The Kaplan Meier method/log-rank test were used to estimate and compare progression free survival (PFS) across cohorts. Results: We identified 139 patients receiving first-line therapy including T. The median age was 58 years and 84 patients were ER and/or PR (+). The top 5 chemotherapy regimens included T plus: paclitaxel (n = 14); docetaxel (n = 14); vinorelbine (n = 14); carboplatin/paclitaxel (n = 12); carboplatin/docetaxel (n = 7 pts). Twenty-one (15%) patients were in cohort A, 55 (40%) were in cohort B, and 63 (45%) were in cohort C. Overall, the median duration of first-line T use was 281 days (mean = 287; range = 1–862). Following the initiation of first-line therapy, a total of 56 (40%) patients progressed (median follow up = 15 months). Following progression, 22 (39%) patients received second-line regimens containing T. The overall median PFS was 17.4 months (mean = 18.6). Patients in cohort A (n = 15) had significantly shorter PFS versus patients in cohort B/C (median 3.9 and 19.6 months, respectively; p < 0.001). Conclusions: In this observational study within the outpatient community setting, persistent first-line T use for MBC was associated with delayed disease progression. Future research should evaluate the causal relationship of this association. In addition, a more comprehensive evaluation should be conducted of therapies prescribed concomitant to T for patients treated with T “monotherapy.” [Table: see text]" @default.
- W2545068059 created "2016-11-04" @default.
- W2545068059 creator A5020368996 @default.
- W2545068059 creator A5032187510 @default.
- W2545068059 creator A5050287319 @default.
- W2545068059 creator A5072015843 @default.
- W2545068059 creator A5085467680 @default.
- W2545068059 date "2009-05-20" @default.
- W2545068059 modified "2023-09-24" @default.
- W2545068059 title "First-line trastuzumab utilization: Patterns of care and progression in the community setting" @default.
- W2545068059 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.e12009" @default.
- W2545068059 hasPublicationYear "2009" @default.
- W2545068059 type Work @default.
- W2545068059 sameAs 2545068059 @default.
- W2545068059 citedByCount "0" @default.
- W2545068059 crossrefType "journal-article" @default.
- W2545068059 hasAuthorship W2545068059A5020368996 @default.
- W2545068059 hasAuthorship W2545068059A5032187510 @default.
- W2545068059 hasAuthorship W2545068059A5050287319 @default.
- W2545068059 hasAuthorship W2545068059A5072015843 @default.
- W2545068059 hasAuthorship W2545068059A5085467680 @default.
- W2545068059 hasConcept C121608353 @default.
- W2545068059 hasConcept C126322002 @default.
- W2545068059 hasConcept C141071460 @default.
- W2545068059 hasConcept C143998085 @default.
- W2545068059 hasConcept C167135981 @default.
- W2545068059 hasConcept C207103383 @default.
- W2545068059 hasConcept C2775930923 @default.
- W2545068059 hasConcept C2776694085 @default.
- W2545068059 hasConcept C2778239845 @default.
- W2545068059 hasConcept C2778336483 @default.
- W2545068059 hasConcept C2778715236 @default.
- W2545068059 hasConcept C2779786085 @default.
- W2545068059 hasConcept C2780350996 @default.
- W2545068059 hasConcept C2780739268 @default.
- W2545068059 hasConcept C2781190966 @default.
- W2545068059 hasConcept C2781413609 @default.
- W2545068059 hasConcept C2781451048 @default.
- W2545068059 hasConcept C44249647 @default.
- W2545068059 hasConcept C530470458 @default.
- W2545068059 hasConcept C71924100 @default.
- W2545068059 hasConcept C72563966 @default.
- W2545068059 hasConceptScore W2545068059C121608353 @default.
- W2545068059 hasConceptScore W2545068059C126322002 @default.
- W2545068059 hasConceptScore W2545068059C141071460 @default.
- W2545068059 hasConceptScore W2545068059C143998085 @default.
- W2545068059 hasConceptScore W2545068059C167135981 @default.
- W2545068059 hasConceptScore W2545068059C207103383 @default.
- W2545068059 hasConceptScore W2545068059C2775930923 @default.
- W2545068059 hasConceptScore W2545068059C2776694085 @default.
- W2545068059 hasConceptScore W2545068059C2778239845 @default.
- W2545068059 hasConceptScore W2545068059C2778336483 @default.
- W2545068059 hasConceptScore W2545068059C2778715236 @default.
- W2545068059 hasConceptScore W2545068059C2779786085 @default.
- W2545068059 hasConceptScore W2545068059C2780350996 @default.
- W2545068059 hasConceptScore W2545068059C2780739268 @default.
- W2545068059 hasConceptScore W2545068059C2781190966 @default.
- W2545068059 hasConceptScore W2545068059C2781413609 @default.
- W2545068059 hasConceptScore W2545068059C2781451048 @default.
- W2545068059 hasConceptScore W2545068059C44249647 @default.
- W2545068059 hasConceptScore W2545068059C530470458 @default.
- W2545068059 hasConceptScore W2545068059C71924100 @default.
- W2545068059 hasConceptScore W2545068059C72563966 @default.
- W2545068059 hasIssue "15_suppl" @default.
- W2545068059 hasLocation W25450680591 @default.
- W2545068059 hasOpenAccess W2545068059 @default.
- W2545068059 hasPrimaryLocation W25450680591 @default.
- W2545068059 hasRelatedWork W1565820605 @default.
- W2545068059 hasRelatedWork W2029620489 @default.
- W2545068059 hasRelatedWork W2107960402 @default.
- W2545068059 hasRelatedWork W2112200394 @default.
- W2545068059 hasRelatedWork W2136224372 @default.
- W2545068059 hasRelatedWork W2439707001 @default.
- W2545068059 hasRelatedWork W2569615035 @default.
- W2545068059 hasRelatedWork W3119397188 @default.
- W2545068059 hasRelatedWork W4232824905 @default.
- W2545068059 hasRelatedWork W4246454966 @default.
- W2545068059 hasVolume "27" @default.
- W2545068059 isParatext "false" @default.
- W2545068059 isRetracted "false" @default.
- W2545068059 magId "2545068059" @default.
- W2545068059 workType "article" @default.